JP2018514523A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514523A5
JP2018514523A5 JP2017553915A JP2017553915A JP2018514523A5 JP 2018514523 A5 JP2018514523 A5 JP 2018514523A5 JP 2017553915 A JP2017553915 A JP 2017553915A JP 2017553915 A JP2017553915 A JP 2017553915A JP 2018514523 A5 JP2018514523 A5 JP 2018514523A5
Authority
JP
Japan
Prior art keywords
tablet
ribocyclic
rib
ribocyclib
succinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017553915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018514523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/052136 external-priority patent/WO2016166703A1/en
Publication of JP2018514523A publication Critical patent/JP2018514523A/ja
Publication of JP2018514523A5 publication Critical patent/JP2018514523A5/ja
Pending legal-status Critical Current

Links

JP2017553915A 2015-04-16 2016-04-14 リボシクリブ錠剤 Pending JP2018514523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562148240P 2015-04-16 2015-04-16
US62/148,240 2015-04-16
PCT/IB2016/052136 WO2016166703A1 (en) 2015-04-16 2016-04-14 Ribociclib tablet

Publications (2)

Publication Number Publication Date
JP2018514523A JP2018514523A (ja) 2018-06-07
JP2018514523A5 true JP2018514523A5 (cg-RX-API-DMAC7.html) 2019-05-23

Family

ID=55806565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017553915A Pending JP2018514523A (ja) 2015-04-16 2016-04-14 リボシクリブ錠剤

Country Status (29)

Country Link
US (6) US10799506B2 (cg-RX-API-DMAC7.html)
EP (3) EP4620458A3 (cg-RX-API-DMAC7.html)
JP (1) JP2018514523A (cg-RX-API-DMAC7.html)
KR (2) KR20250009572A (cg-RX-API-DMAC7.html)
CN (2) CN107530292B (cg-RX-API-DMAC7.html)
AR (1) AR104257A1 (cg-RX-API-DMAC7.html)
AU (5) AU2016248017A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017021283A2 (cg-RX-API-DMAC7.html)
CA (1) CA2982425C (cg-RX-API-DMAC7.html)
CL (1) CL2017002593A1 (cg-RX-API-DMAC7.html)
CO (1) CO2017010510A2 (cg-RX-API-DMAC7.html)
DK (1) DK3283058T3 (cg-RX-API-DMAC7.html)
EA (1) EA201792290A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP17075052A (cg-RX-API-DMAC7.html)
ES (1) ES2938261T3 (cg-RX-API-DMAC7.html)
FI (1) FI3283058T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20230053T1 (cg-RX-API-DMAC7.html)
HU (1) HUE061213T2 (cg-RX-API-DMAC7.html)
IL (1) IL254818A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017013350A (cg-RX-API-DMAC7.html)
PE (1) PE20180035A1 (cg-RX-API-DMAC7.html)
PH (1) PH12017501820A1 (cg-RX-API-DMAC7.html)
PL (1) PL3283058T3 (cg-RX-API-DMAC7.html)
PT (1) PT3283058T (cg-RX-API-DMAC7.html)
SG (1) SG11201708084PA (cg-RX-API-DMAC7.html)
SI (1) SI3283058T1 (cg-RX-API-DMAC7.html)
TN (1) TN2017000422A1 (cg-RX-API-DMAC7.html)
TW (1) TW201642864A (cg-RX-API-DMAC7.html)
WO (1) WO2016166703A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017013350A (es) * 2015-04-16 2018-01-25 Novartis Ag Comprimido de ribociclib.
CA3048036A1 (en) 2018-07-02 2020-01-02 Apotex Inc Novel crystalline form of ribociclib succinate
AU2020336309A1 (en) 2019-08-26 2022-03-17 Arvinas Operations, Inc. Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
CR20220342A (es) 2019-12-16 2023-01-23 Lunella Biotech Inc Agentes terapéuticos selectivos contra el cáncer inhibidores cdk4/6
US12358920B2 (en) 2019-12-16 2025-07-15 Lunella Biotech, Inc. Substituted pyrrolo[2,3-d]pyrimidines as selective CDK 4/6 inhibitors
BR112023001454A2 (pt) * 2020-08-03 2023-02-14 Natco Pharma Ltd Composição de comprimido de liberação imediata e processo para a preparação da composição
MX2022015336A (es) * 2020-09-29 2023-01-11 Laboratorios Silanes S A De C V Combinaciones farmaceuticas de estatinas y fibratos para el tratamiento y prevencion de hiperlipidemias y enfermedades cardiovasculares.
WO2022162122A1 (en) 2021-01-29 2022-08-04 Biotx.Ai Gmbh Genetically verified netosis inhibitor for use in the treatment of a sars-cov2 infection
AU2022311961A1 (en) 2021-07-16 2023-11-09 Dana-Farber Cancer Institute, Inc. Small molecule cyclin dependent kinase 4/6 (cdk4/6) and ikzf2 (helios) degraders and methods of use thereof
TWI848533B (zh) 2022-01-25 2024-07-11 瑞士商諾華公司 瑞博西尼藥物組成物
JP2025530742A (ja) 2022-08-31 2025-09-17 アルビナス・オペレーションズ・インコーポレイテッド エストロゲン受容体分解物質の投与計画
EP4626890A1 (en) 2022-12-01 2025-10-08 KRKA, d.d., Novo mesto Ribociclib salts and formulations thereof
KR20250163966A (ko) 2023-03-27 2025-11-21 노파르티스 아게 리보시클립과 아로마타제 저해제를 병용하여 초기 유방암을 치료하는 방법
WO2025219830A1 (en) 2024-04-15 2025-10-23 Novartis Ag Pharmaceutical compositions of ribociclib

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5428812A (en) * 1977-08-09 1979-03-03 Yoshitomi Pharmaceut Ind Ltd Preparation of coated tablet
GB9414045D0 (en) 1994-07-12 1994-08-31 Berwind Pharma Service Moisture barrier film coating composition, method, and coated form
AU703933B2 (en) * 1994-07-12 1999-04-01 Berwind Pharmaceutical Services, Inc. Moisture barrier film coating composition, method, and coated form
US6448323B1 (en) * 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
BRPI0917791B1 (pt) 2008-08-22 2022-03-22 Novartis Ag Compostos de pirrolopirimidina como inibidores de cdk, bem como composição farmacêutica e combinação
US8807979B2 (en) * 2009-09-24 2014-08-19 Mcneil-Ppc, Inc. Machine for the manufacture of dosage forms utilizing radiofrequency energy
US20120115878A1 (en) 2010-11-10 2012-05-10 John Vincent Calienni Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
AU2011358840B2 (en) * 2011-02-11 2017-05-04 TauRx Therapeutics Management Ltd Phenothiazine diaminium salts and their use
LT2872482T (lt) * 2012-07-13 2020-12-28 Oncternal Therapeutics, Inc. Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi
EP2742940B1 (en) * 2012-12-13 2017-07-26 IP Gesellschaft für Management mbH Fumarate salt of (R)-3-(6-(4-methylphenyl)-pyridin-3-yloxy)-l-aza-bicyclo-[2.2.2]octane for adminstration once daily, twice daily or thrice daily
ES2676177T3 (es) * 2012-12-20 2018-07-17 Novartis Ag Una combinación farmacéutica que comprende binimetinib
AU2014233805B2 (en) * 2013-03-21 2018-10-18 Array Biopharma Inc. Combination therapy comprising a B-Raf inhibitor and a second inhibitor
EP2810644A1 (en) * 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
MX2017013350A (es) * 2015-04-16 2018-01-25 Novartis Ag Comprimido de ribociclib.
CN109953966A (zh) * 2017-12-26 2019-07-02 天津耀辰实业发展有限公司 一种含有瑞博西尼的药物组合物及其制备方法
JP7347388B2 (ja) 2020-09-25 2023-09-20 信越化学工業株式会社 紫外線硬化型有機変性シリコーン組成物および硬化物

Similar Documents

Publication Publication Date Title
JP2018514523A5 (cg-RX-API-DMAC7.html)
HRP20230053T1 (hr) Tableta ribocikliba
JP2007302683A5 (cg-RX-API-DMAC7.html)
JP2014218522A5 (cg-RX-API-DMAC7.html)
JP2012255026A5 (cg-RX-API-DMAC7.html)
JP2018184433A5 (cg-RX-API-DMAC7.html)
JP2015078230A5 (cg-RX-API-DMAC7.html)
JP2012530141A5 (cg-RX-API-DMAC7.html)
JP2015205922A5 (cg-RX-API-DMAC7.html)
MX394584B (es) Preparación que comprende vonoprazán.
JP2014167026A5 (cg-RX-API-DMAC7.html)
JP2017048194A5 (cg-RX-API-DMAC7.html)
JP2009545560A5 (cg-RX-API-DMAC7.html)
CN109415406A (zh) 羊毛甾醇前药化合物及其制备方法和应用
JP2018529964A5 (cg-RX-API-DMAC7.html)
JP2017515879A5 (cg-RX-API-DMAC7.html)
JP2014218523A5 (cg-RX-API-DMAC7.html)
RU2015140119A (ru) Таблетка, покрытая кишечнорастворимым покрытием
CN109803654A (zh) 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法
JP2020099679A5 (cg-RX-API-DMAC7.html)
CN106794183A (zh) 含有细胞周期蛋白抑制剂的药物制剂及其制备方法
JP2018039810A5 (cg-RX-API-DMAC7.html)
JP2019504848A5 (cg-RX-API-DMAC7.html)
JP2016516031A5 (cg-RX-API-DMAC7.html)
JP2014169318A5 (cg-RX-API-DMAC7.html)